Infected girl’s ‘dine with a stranger with Hepatitis B’ awareness campaign

New Delhi, May 18 (ANI): A Chinese girl with Hepatitis B found a unique way to raise awareness about the virus—she took to the streets holding a sign saying “Will you have dinner with a HBV carrier”.

The girl, an overseas returnee who calls herself Chucao, told reporters in downtown Wuhan, capital of Hubei province, that she was diagnosed as a carrier of HBV – Hepatitis B Virus – during a physical examination to enter high school.

However, her family got scared of the stigma attached to the illness and forced her to keep it a secret and move away.

Chucao then entered a college in Japan, where she found HBV is not regarded as a terrible disease like it is in China, reports the China Daily.

Back in China, Chucao encountered some other HBV carriers though the Internet and they formed an organization named Green Chucao.

The organization committed itself to publishing scientific knowledge of HBV by carrying out activities such as inviting people to have dinner with sufferers.

Before coming to Wuhan, Chucao carried out similar activities in Guangzhou, Nanjing, Suzhou and Kunshan.

Not only did she encounter difficulties, but also kind-hearted people—one girl even donated 300 yuan.

In the afternoon, 14 volunteers agreed to go to a restaurant to have dinner with Chucao.

They used disposable dishware and the atmosphere was reported as relaxing.

Medical expert said healthy people who have dinner with HBV carriers would not become infected as transmission does not occur through daily contact.

Chucao hoped the news would help get rid of people’s discrimination of HBV carriers. (ANI)

Police investigate hep C infections

Victorian police are trying to find out whether a doctor deliberately infected 12 women with hepatitis C.

The women were all patients at a Melbourne abortion clinic between June 2008 and December 2009.

The state’s health department went public with its suspicions on Friday, but the department and the Victorian health minister are defending the decision to keep the matter quiet until now.

Suspicions were raised when the Victorian Department of Health noticed in December that three women diagnosed with hepatitis C had all been patients of the same clinic.

When a further nine cases were linked to the clinic early this year the department decided the police needed to be notified.

Victoria’s chief health officer, Dr John Carnie, says he cannot explain how 12 people could be infected by accident.

“I find it difficult to imagine how an accidental transmission could affect 12 patients and because of that difficulty we have tried to involve the police and the medical board in this investigation,” Dr Carnie said.

Dr Carnie would not say what sort of procedures the women had undergone, but it was confirmed today that the doctor is an anaesthetist.

He had been working at the clinic at Croydon in Melbourne’s outer-east.

The Victorian Health Department started testing the clinic’s staff in January, but at that time the doctor was overseas. He was tested on his return to Melbourne in early February.

Dr Carnie says it was confirmed the doctor had hepatitis C. Further testing, which Dr Carnie likens to testing fingerprints, showed that three of the women had the same strain of hepatitis C as the doctor.

It is known as genotype 1B and is a relatively rare form of the virus in Australia.

The Medical Practitioners Board declined to say if the doctor is from overseas.

Dr Carnie says the Victorian Health Department did a great job in identifying the hepatitis C cluster.

“We get over 2,000 cases of hepatitis C being notified to the Department. Out of those 2,000-odd cases in total, being able to find this very small number of cases that have this link to the clinic has been the result of very detailed and painstaking work on the part of the communicable disease area,” he said.

People who underwent surgery at the clinic between June 2008 and December 2009 are being contacted by the Department of Health.

But Dr Carnie will not speculate on the number of people that may have been infected.

“This whole episode is going to clearly cause distress in the community. I don’t want to add to that concern by starting to speculate on total numbers,” he said.

Of the 12 women who tested positive to hepatitis C, two have now cleared the virus from their bloodstreams, which Dr Carnie says is not unusual.

The other 10 women are at risk of developing cirrhosis of the liver or liver cancer.

But Dr Carnie says that anti-viral treatment can cure some cases.

Notification process

The doctor in question was suspended in mid-February after already giving the Victorian Department of Health an undertaking not to practice while the matter was being investigated.

Dr Carnie has defended the amount of time it took to suspend the doctor.

“From the time the clinic reopened after the holidays there was no ongoing risk to anyone and this person has not worked at that clinic since his return from overseas,” he said.

The President of the Victorian Medical Practitioners Board, Robert Adler, says doctors who have Hepatitis C are allowed to practice, but only if they follow infection control procedures and don’t do what are known as “exposure prone surgical procedures” like those in internal cavities or those with a higher risk of needle stick injury.

“Normal anaesthesia that follows infection control guidelines carries an extremely low or non-existent risk of transmission of Hepatitis C provided the doctor follows infection control guidelines,” he said.

The hepatitis C cluster was revealed in Melbourne’s Herald Sun newspaper this morning. Dr Carnie says it was not necessary to notify the public earlier.

“We are in the process of starting to call people back, other people who may have had procedures at this clinic and we didn’t want them to be alarmed by a call from the Department,” he said.

“We we wanted them to be aware of the issue that we’re dealing with and that was the reason for making this public.”

Victorian Health Minister, Daniel Andrews, says he was notified of the initial cluster of three cases of Hepatitis C on the December 22 last year.

He does not believe the public should have been notified earlier.

“I am confident that the chief health officer and my department, more broadly, have made appropriate contacts with Victoria Police and I’m confident that my department and the chief health officer have at all times, and at all stages, acted appropriately in relation to these issues,” Mr Andrews said.

Abortion clinic doctor infected women with hep C

Fears of a public health threat are being hosed down by authorities in Victoria after the revelation a doctor has been suspended from practice because 12 of his female patients have contracted Hepatitis C.

The anaesthetist has the disease and police and the Medical Practitioners Board are investigating how it was transmitted to the women.

The Department of Human Services says DNA tests have linked the strain of the virus found in the women to the strain the doctor has.

The doctor has not been named, but he was working at an abortion clinic in Melbourne between June 2008 and December 2009.

Critics say the public should have been notified about the possibility of infection far sooner.

Hepatitis C takes a long time to surface. It can cause fatal liver problems and is very hard to treat.

People with the infection can pass it on if their blood gets under the skin or into the bloodstream of another person, possibly through the use of a shared syringe.

In this instance the anaesthetist passed his Hepatitis C onto 12 women, many of whom were pregnant when they were infected with the disease between June 2008 and December last year.

At the time the anaesthetist was working at the Croydon Day Surgery in outer east Melbourne.

Health authorities do not know how it happened. They do not believe anyone else has been infected but they cannot guarantee it.

Victoria’s chief health officer, Dr John Carnie, says other people who visited the surgery are being tested.

“I mean I am pretty confident that if there were any other notified cases we would have picked them up. But for completeness sake we are going to call these other people back and get them tested as well,” he said.

Accident or deliberate?

Dr Carnie says he cannot explain how 12 people could be infected by accident.

“Accidents might involve say one or two patients, but we are dealing with a cluster of 12 patients. So at this stage there is nothing in the processes and procedures at this clinic that would enable me to explain how it happened,” he said.

He says investigations began in December when three people presented with Hepatitis C who had each been treated at the clinic over a six-month period.

Officers asked for all staff involved in surgical procedures to be tested.

“All of the staff at the time tested negative except for one of their medical practitioners who happened to be overseas at that time,” Dr Carnie said.

“So on that person’s return from overseas we arranged for that person to be tested – and this was at the beginning of February – and the results were clear, the person was Hepatitis C positive.

“We then asked the lab to conduct what are called sequencing studies. What it means is comparing the structure of a virus that you get from patients and comparing that structure with the virus that was obtained from the doctor concerned; similar to I guess doing a kind of fingerprint matching if you like.

“And the laboratory has found that there is a clear link from a structural point of view between the viruses of the three patients that we initially identified and that of the doctor.”

Notification criticism

There are concerns authorities took too long to notify the public about the possibility of infection.

National president of the Maternity Coalition, Lisa Metcalfe, says it has taken a long time for authorities to act and women are vulnerable.

“Where medical practitioners have been acting inappropriately and it has taken the Health Department some time – I mean 12 cases is a lot of women to be exposed to this kind of alleged abuse,” she said.

“It has taken a long time for them to actually act on it and to have effect, take effect and to do something about reining these medical practitioners in.”

In 2008 in the United States a district health authority in Nevada issued a public warning and called on people who had used a Las Vegas clinic over a four-year period to be tested for Hepatitis C and HIV.

The warning came after an investigation found the clinic had been responsible for unsafe anaesthesia injection practices.

The Southern Nevada Health District identified six cases of Hepatitis C at the clinic, five of which stemmed from procedures on the same day involving anaesthesia.

It said a syringe that was used to administer anaesthetics to one patient may have contaminated the vial from which the anaesthetics were drawn. Intended for single use only, the vial was subsequently reused.

The district advised 40,000 patients to contact their doctors and get tested for the disease.

Nothing like this happened in Victoria. Instead authorities went to the clinic and asked for a record of patients. Officials are gradually going through the list and contacting patients one by one.

Chief health officer Dr John Carnie says they did not want to alarm members of the public by issuing a warning in the first place back in February.

“We are in the process of starting to call people back, other people who may have had procedures at this clinic,” he said.

“We didn’t want them to be alarmed by a call from the department but we wanted them to be aware of the issue that we are dealing with, and that was the reason for making this public.”

Natalie Cole makes comeback after kidney transplant op

Washington, September 11 (ANI): R andB singer Natalie Cole made a comeback to the stage and performed at a concert in Hollywood after fighting severe health conditions for almost a year.

“I really do have to say … it really is a miracle time. It’s a miracle night for me. I never thought I’d be standing here healthy and whole and 100 percent,” People magazine quoted her as telling the crowd present.

The singer was diagnosed with Hepatitis C in April last year.

Apart from treating the liver disease with chemotherapy, she also battled kidney problems later that year.

However, she was back with a bang at the Hollywood Bowl belting out hits like ‘This Will Be,’ ‘Our Love,’ and ‘Unforgettable’

She said: “My heart is very full tonight, and I know a lot of you know why. It’s just good to be back. You know what I’m saying?

“You know, things don’t always go the way we want it to. Things happen unexpectedly. You got to take the good with the bad.”

Cole also brought the attention of the audience to health problems.

She said: “One in eight people has kidney failure. That’s a lot of people and I never thought it would happen to me, but here we are.”

She described the phase she was ill as “a real tough journey.” (ANI)

Armani ‘marvellously well’ after winning battle with hepatitis

London, Sep 11 (ANI): Italian fashion designer Giorgio Armani has said that he is feeling “marvellously well” after winning a long battle with hepatitis.

According to Ansa news agency, Armani, 75, who was at Vogue Fashion’s Night Out in Milan, Italy, and a perfume launch, said that his liver was in such good shape that he could stop taking the medicine he had been on.

Armani had revealed in May that he had been battling hepatitis, and after several missed public appearances in spring, and a gaunt appearance at the June Italian menswear shows, there were concerns about his health.

“I’m marvellously well, I beat my problem. The data about my liver are nearly perfect – some even better than perfect – such that I can stop taking my medicine,” the Daily Express quoted him as saying.

The tanned designer said he had also just returned from a long, relaxing vacation cruising around Croatia, Italy’s southern coast and the islands off Sicily before ending up at his home on the island of Pantelleria. (ANI)

Satyam founder Raju placed under medial observation for 48 hours

Hyderabad, Sep 8 (ANI): Satyam Computers founder B Ramalinga Raju, who suffered a massive heart attack on Monday, has been put under observation for next 48 hours in the Intensive Care Unit (ICU) of the Nizam’s Institute of Medical Sciences (NIMS) hospital.

According to hospital sources, Raju has also been diagnosed with the Hepatitis C.

Doctors said, Raju’s condition is stable and that he needed rest for a long period.

According to jail sources, Raju suffered a cardiac arrest at around 8 p.m, was initially attended by the jail doctors before being shifted to NIMS hospital.

Raju, who has been under judicial custody at the Chanchalguda jail for the past eight months in connection with Rs 8,000 crore corporate fraud, facing criminal charges including fraud, forgery, cheating, embezzlement and insider trading along with his brother and Satyam’s former managing director Rama Raju and others.

Raju, will turn 55 on September 16.

Raju was Satyam’s Chairman until January 7, 2009 when he resigned from the company’s board after admitting to corporate fraud. The Andhra Pradesh Police arrested him on January 9.

Satyam was created by Raju and others and was until recently perceived to be among the top Indian IT companies. (ANI)

Hepatitis B virus mutations may help predict liver cancer risk

Washington, July 3 (ANI): Scientists from Second Military Medical University in Shanghai have revealed that mutations in the DNA of hepatitis B virus (HBV) might help predict which patients are at increased risk of developing liver cancer,

HBV infection is a known cause of hepatocellular carcinoma (HCC), the most common form of liver cancer.

During the research, the team analysed 43 studies with a total of 11,582 HBV-infected participants, of whom 2,801 had HCC.

They found that certain mutations were associated with development of HCC, and more prevalent as chronic HBV infection progressed from the asymptomatic state to liver cirrhosis or HCC.

“Frequent examination of patients with chronic HBV infections for the presence of these mutations may be useful for identifying which patients require preventive antiviral treatment and for the prediction of HCC,” wrote the authors.

The study appears in Journal of the National Cancer Institute. (ANI)

‘Ridiculously drunk’ mom knees daughter’s school principal in the groin

Melbourne, Jun 25 (ANI): A woman, who was in a very inebriated state, could not recall punching, spitting and kneeing her daughter’s school principal in the groin.

Karen Lee Pommer, 47, attacked Jeff Munce when she went to pick up her eight-year-old daughter from Warrigal Road State School in the Brisbane suburb of Eight Mile Plains on October 31 last year.

The Brisbane District Court was told on June 25 that Pommer entered the school grounds screaming obscenities while the students waited to be collected at the end of the day.

When Munce approached her she punched his head repeatedly, then kneed him in the groin and spat in his face.

She also slapped and spat at another mother who tried to intervene.

The court was told Pommer – who was infected with hepatitis C – then spat at and bit three police officers who arrived to arrest her.

None of her victims contracted the highly infectious disease.

When she was hauled into the police vehicle, she then wriggled free from her handcuffs and smashed one of the windows.

Defence barrister Jann Taylor said Pommer, a chronic alcoholic, had been suffering an “alcohol-induced blackout”‘ when she went to the school.

“She was ridiculously drunk to the point of no recollection,” News.com.au quoted Taylor as saying.

Pommer pleaded guilty to 10 offences including three counts of serious assault and two of common assault.

Judge Leanne Clare sentenced her to two years’ jail but released her on parole immediately. (ANI)

Environmental pollution raises liver disease risk

Washington, May 30 (ANI): Environmental pollution increases the risk of liver disease, says a new US study.

The research is the first to show that there is a previously unrecognized role for environmental pollution in liver disease in the general U.S. adult population.

The study is being presented during Digestive Disease Week 2009 (DDW), the largest international gathering of physicians and researchers in the fields of gastroenterology, hepatology, endoscopy and gastrointestinal surgery.

“Our study found that greater than one in three U.S. adults had liver disease, even after excluding those with traditional risk factors such as alcoholism and viral hepatitis,” said Matthew Cave, MD, assistant professor, department of medicine, division of gastroenterology and hepatology at the University of Louisville.

“Our study shows that some of these cases may be attributable to environmental pollution, even after adjusting for obesity, which is another major risk factor for liver disease,” he added.

Using the 2003-2004 National Health and Nutrition Examination Survey (NHANES), researchers from the University of Louisville study examined chronic low-level exposure to 111 common pollutants including lead, mercury, PCBs and pesticides and their association with otherwise unexplained liver disease in adults. The specific pollutants included were detectable in 60 percent or more of the 4,500 study subjects.

Dr. Cave added that this analysis used only the ALT liver enzyme as a marker of liver injury, and cautioned that this associative study does not prove causality.

However, he added that previous animal studies do suggest causality for many of these chemicals. Dr. Cave and his co-authors also plan to examine the additive effects of environmental pollutants on liver disease in children and adults with risk factors including obesity, viral hepatitis, and alcoholism in the NHANES population. (ANI)

Natalie Cole ‘discharged from hospital’

Washington, May 26 (ANI): Singer Natalie Cole has reportedly been released from the hospital after undergoing a kidney transplant and is said to be recuperating.

Natalie, who suffered a kidney failure caused by hepatitis C, was discharged five days after her kidney transplant.

“Natalie is continuing to do well under the circumstances,” People quoted Natalie’s representative, as saying.

Sadly for Natalie, who had planned to attend a private family memorial service for her sister Carol “Cookie” Cole, who passed away following a battle with lung cancer, had to undergo the life-saving organ transplant on the very same day.

Meanwhile, Natalie is expected to spend the next three to four months recuperating and will reorganize her tour dates in support of her album Still Unforgettable. (ANI)

Natalie Cole loses sister to death

New York, May 23 (ANI): Natalie Cole underwent a life-saving kidney transplant surgery in Los Angeles and returned to her ailing sister’s bed, only to learn she had passed away.

The 59-year-old singer had been with her dying sister, Carol “Cookie” Cole when she received an urgent call from medics, saying that a kidney had been arranged from a deceased organ donor and that she would have to undergo surgery immediately.

And as the eight-time Grammy Award-winner, who has been suffering from kidney failure, caused by the hepatitis C she contracted during her time as an intravenous heroin user, was receiving the life-saving transplant after a few hours, her elder sister left the world.

“Natalie was there with her at her bedside at 4 in the morning on Monday, and she got a phone call from her doctors that a kidney was ready for her,” the New York Post quoted Natalie’s younger sister, Timolin Cole, as saying.

“She said, ‘What do you mean? I can’t deal with that right now! I’m here with my dying sister!’ And they said to her, ‘No, ma’am. We’ve got to do it now. You’ve got to be at Cedars-Sinai in two hours.’

“I told her, ‘Natalie, this is God’s gift, and you’ve got to go now. Cookie would want this for you,’” she added.

Timolin continued: “This is all so surreal, and it is devastating.

“Our sister Cookie hadn’t been to a doctor in 30 years, and last week she went in and they found a cancerous spot on her lung. They had wanted to start chemo right away, but Cookie said no.”

Natalie’s publicist called the family’s life-and-death parallels “a tragic coincidence.” (ANI)

Natalie Cole recovering from kidney transplant

Washington, May 21 (ANI): Ailing singer Natalie Cole recently underwent a life-saving kidney transplant surgery in Los Angeles, and was “resting comfortably,” according to her representative.

The 59-year-old has been suffering from kidney failure, caused by the hepatitis C she contracted during her time as an intravenous heroin user.

The eight-time Grammy Award-winner, who has been getting treated since September last year, had been put on a waiting list for a replacement organ.

“The kidney came from a deceased organ donor through the regional organ procurement agency, One Legacy,” People magazine quoted her rep as saying in a statement.

Cole is expected to recuperate for the next three to four months and is allegedly planning to re-arrange her summer tour dates in support of her album Still Unforgettable. (ANI)

Added anti-viral boosts response, shortens hepatitis C treatment duration

London, April 30 (ANI): A new study, conducted by researchers at the Duke Clinical Research Institute (DCRI), has found that adding the anti-viral drug telaprevir to a standard treatment for hepatitis C can shorten the duration of therapy and increase the number of patients who can be cured of their disease.

“Standard treatment for the most common type of hepatitis C is 48 weeks of a combination of two drugs, peginterferon alfa-2a and ribavirin, which cures less than half of patients and has significant side effects that make it very difficult for some patients to continue their treatment,” said John McHutchison, M.D., a hepatologist and gastroenterologist and researcher at the DCRI, and lead investigator on this study.

“Our study found that by combining the standard therapy with the direct anti-viral drug telaprevir, we could reduce the duration of treatment by 50 percent, to 24 weeks, and, at the same time, improve the cure rate by 50 percent,” he added.

Telaprevir is a protease inhibitor that works by blocking an enzyme that the hepatitis C virus needs in order to replicate itself.

In a randomized, Phase IIb, double-blinded, 37-center study of telaprevir in combination with peginterferon alfa-2a and ribavirin, the researchers examined the responses of 250 patients on four trial arms.

The researchers measured rates of sustained viral response – or SVR – defined as 24 weeks during which the hepatitis C virus remains undetectable in the body after the completion of therapy.

“We observed that 67 percent of patients who received standard therapy for 48 weeks in conjunction with 12 weeks of telaprevir were cured of their hepatitis C,” McHutchison said.

“The rate was 61 percent in the group that took the standard therapy for only 24 weeks in combination with 12 weeks of telaprevir, suggesting that many patients may respond to treatment in only six months as compared to about eleven months, which is significant for this patient population, because the side effects of treatment can be so intense,” McHutchison added.

McHutchison said that the group, which received standard therapy for up to 48 weeks had a sustained viral response rate of 41 percent.

He said that the most frequently reported adverse side effect associated with telaprevir was a rash that was manageable in some patients, but caused others to discontinue the treatment.

The findings have been published in the April 30, 2009 issue of the New England Journal of Medicine. (ANI)

Natalie Cole fears she will run out of time before kidney transplant

London, April 28 (ANI): Natalie Cole is terrified that she may not have enough time on her hands to undergo a life-saving kidney transplant.

The 59-year-old singer has been suffering from kidney failure caused by the chronic liver disease Hepatitis C.

The eight-time Grammy Award-winner contracted the condition from her drug addiction during the 80s and is being treated since September last year.

Cole has been put on a waiting list for a replacement organ but she fears the transplant may never come and has now left her fate to the Almighty.

“At the moment, where it’s coming from, heaven only knows,” the Daily Star quoted her as telling Los Angeles Confidential magazine. (ANI)

Diabetes, obesity, hypertension up mortality in hepatitis C patients

Washington, Apr 23 (ANI): Type 2 diabetes, obesity and hypertension are associated with overall and liver related mortality in hepatitis C (HCV) infected patients, a new research has claimed.

The specific impact of metabolic syndrome on mortality in hepatitis C patients has been revealed by new research to be presented on Sunday April 26 at EASL 2009, the Annual Meeting of the European Association for the Study of the Liver in Copenhagen, Denmark.

In HCV-infected patients, the top three predictors of liver related mortality were having higher body mass index (BMI), presence of insulin resistance (IR) and elevated serum cholesterol. Overall mortality in HCV patients was most linked to metabolic syndrome, higher BMI and hypertension.

Metabolic syndrome is a combination of medical problems that increase risks of cardiovascular disease and diabetes.

Recent data have suggested that metabolic syndrome is associated with adverse outcomes in HCV patients. This study set out to assess which aspects of metabolic syndrome are of most risk to such HCV patients and to quantify their specific impact on mortality.

Professor Zobair Younossi MD, MPH from the Center for Liver Diseases at Inova Fairfax Hospital and the Executive Director of Betty and Guy Beatty’s Center for Integrated Research, Virginia, USA, who led the study, said: “Exploring the risk factors associated with adverse outcomes in HCV patients helps us to better understand the complex nature of this highly prevalent disease.

“This study shows a clear association between key components of metabolic syndrome and mortality in HCV patients and demonstrates the importance of lifestyle improvements and coaching in the management of HCV patients, to potentially minimise the onset and impact of metabolic syndrome and its associated mortality risks.”

Researchers in this study utilised the Third National Health and Nutrition Examination Survey (NHANES III) and Linked Mortality Files. HCV was defined as positive HCV RNA by PCR assay. Subjects without other causes of chronic liver disease such as presumed NAFLD with elevated serum aminotransferases, excessive alcohol use, elevated transferrin saturation and positive hepatitis Bs antigen were designated controls without liver disease. HCV patients were compared to HCV-negative individuals and controls without liver disease using Rao-Scott chi-square statistics.

Adjusted hazard ratios for overall mortality and cause-specific mortality were calculated for HCV patients using persons without HCV. The Cox proportional hazard model was used for calculation of AHR for independent risk factors, and for the presence of HCV as a potential risk factor for overall mortality and cause-specific mortalities.

The cohort included 15,866 individuals with complete data. (ANI)

Groundbreaking First Response Spray Now Available in Europe

Solution Provides 99.99 Percent Reduction of Many Dangerous Pathogens

UNION, Ky., April 15 /PRNewswire/ — Union Springs Pharmaceuticals, LLC today
announces the European distribution of its flagship product, MyClyns, a
portable spray that reduces 99.99 percent of many harmful pathogens and helps
prevent infection. European first responders and public safety officials will
now have access to the spray, which is a critical component to effective,
portable protection.

(Photo: http://www.newscom.com/cgi-bin/prnh/20090415/CL99689 )

MyClyns is available from a number of distributors throughout Europe.

After coming into contact with bodily fluids from a potentially infected
person, first responders can quickly and easily spray MyClyns in their eyes,
mouth or on other points of contact. Response time is critical to lower the
chances of becoming infected after an exposure, and MyClyns offers immediate
protection.

The pocket-sized units contain a powerful solution that has been found to
reduce 99.99 percent of HIV-1, Hepatitis C, MRSA, TB, and 60 pathogens in
independent laboratory testing. The spray is alcohol-free and proven safe for
use on all mucous membranes, including the eyes, ears, nose, and mouth.

“MyClyns has found significant success within the public safety sector, as
first responders are frequently exposed to the dangers of bodily fluids and
other harmful pathogens,” says Union Springs Pharmaceuticals president Joel
Ivers. “The expansion of this product into European markets is in response to
the need for personal protection anywhere in the world where public safety
officials risk dangerous exposure.”

The spray has already proven to be an asset to public safety officials,
military, corrections, and EMS in the United States and Canada.

New Orleans EMS Deputy Director Carl Flores agrees. “One of our employees had
a combative patient who was HIV positive spit in his face,” said Flores. “He
used MyClyns and felt better knowing it was readily available for this
incident. As a manager, I cannot tell you how pleased I am to provide our
employees with this added layer of protection and sense of confidence when
they needed it most.”

Visit www.myclyns.eu for more information about the product.

About Union Springs Pharmaceuticals, LLC
Union Springs Pharmaceuticals, LLC specializes in providing innovative
infection control products for the EMS, fire, law enforcement, corrections,
military, government, healthcare, and consumer markets. Union Springs
Pharmaceuticals offers personal and environmental exposure response products
including MyClyns, the revolutionary personal protection spray that can be
applied into the eyes, nose, and mouth. Union Springs also offers the T-5000
and T-5000V P95 respirators, the only disposable respirators with
antibacterial and antiviral technology. More information on Union Springs
Pharmaceuticals and its products can be found at www.uspharma.com.

SOURCE Union Springs Pharmaceuticals, LLC

Bryan Reynolds, Union Springs Pharmaceuticals, LLC, +1-859-384-4029,
breynolds@uspharma.com

Natalie Cole undergoes chemotherapy in dressing room

Washington, Apr 15 (ANI): Renowned vocalist Natalie Cole, who is known for her utter professionalism, decided to undergo chemotherapy treatment in her concert dressing room, in a bid to continue performing.

Cole, who is battling with Hepatitis C, did not check into a hospital to get treated because she did not want to take time off from work.

However, Cole did agree that Chemotherapy does leave a patient in incredible pain.

“Whatever horror stories you have heard about chemo is true. It is absolutely one of the most debilitating and difficult experiences that could ever happen to a human being. Trying to perform was a real challenge. Just picture an IV (intravenous) hanging from a wardrobe rack in my dressing room in Japan as I tried to prepare for two shows in a night,” Contactmusic quoted her as saying.

Meanwhile, Cole’s chemotherapy has sadly caused her kidneys to fail, and she’s currently hoping for a life-saving transplant. (ANI)

New TB vaccine found safe in Phase I trial

Washington, April 8 (ANI): A leading new tuberculosis vaccine, called MVA85A, has been found to be safe in its Phase I trial.

Lead researcher Dr. Helen McShane, reader in vaccinology and Wellcome senior fellow at the University of Oxford’s Jenner Institute in England, studied the effects of the vaccine specifically in people who had latent tuberculosis infection (LTBI), which can cause full-blown disease when re-activated.

For the study, the researchers recruited 12 individuals with LTBI, who did not have other complicating factors like HIV or hepatitis.

“We had two aims in mind with this study,” the researchers said.

“First, we wanted to demonstrate that MVA85A was safe in individuals with LTBI, and to ensure we were not inducing any immunopathology with this vaccine. Secondly, we wanted to investigate the immunogenicity of this vaccine in individuals with LTBI and compare that with previous findings in individuals who had been BCG vaccinated,” they added.

The patients were vaccinated with the MVA85A vaccine, and followed for 12 months.

Blood tests and diary cards were used to identify any adverse reactions to the vaccine, and the researchers monitored serum inflammatory markers to monitor for any signs of immunopathology.

The research team found that the vaccine was safe, and did not induce any immunopathology in the subjects.

They also observed that vaccination with MVA85A in LTBI-infected individuals seemed to produce a powerful/potent immune response comparable to previous trials in BCG vaccinated people.

Mild local side effects at the site of vaccination were common, and mild systemic side effects-such as headache and fatigue-occurred in up to 50 percent of subjects, but these all resolved spontaneously.

There were no significant increases in serum inflammatory markers.

Dr. McShane says: “The results of this trial are very important, as they suggest MVA85A is safe and highly immunogenic in people who are infected with M. tuberculosis.”

She adds: “Further, larger trials are needed in TB endemic areas to assess the efficacy of this vaccine against the development of TB disease, but these results are very encouraging and justify the further development of this vaccine.”

The results of the trial have been published in the American Journal of Respiratory and Critical Care Medicine. (ANI)

Indians living in UK and Wales at greater risk of drink-related death

Washington, Mar 20 (ANI): Men born in India, but living in England and Wales, are twice as likely to die alcohol-related deaths as the rest of the population, according to a new study led by an Indian-origin scientist.

Conducted by the University of Edinburgh and the Office for National Statistics, the research also found that an equal number of alcohol-related deaths in England and Wales were reported among people born in Scotland or Ireland.

The findings also showed that people born in parts of Asia or Africa were at greater risk of dying from liver cancer, but generally had lower rates of alcohol-related deaths.

On reason for the higher rate of death from liver cancer could be because viral hepatitis is more common in ethnic minority communities.

For the study, the researchers used information on deaths for England and Wales from 1999 to 2003 and figures from the 2001 census to quantify the link between a person’s country of birth and the likelihood of dying from an alcohol-related condition.

The difference in alcohol-related deaths rates could be explained by cultural differences in rates of alcohol consumption.

For example, adults who are Scottish or Irish have been shown on average to drink more than the recommended limit of alcohol.

The study comes in line with recent reports that alcohol-related hospital admissions in the over 65s are rising.

“Deaths from alcohol-related conditions, liver disease and liver cancer are increasing in the UK, but little is known about the role of ethnicity or country of birth. Some ethnic groups appear to be setting an example for the population as a whole with very low rates of liver disease, almost certainly as a result of low alcohol consumption,” said Dr Neeraj Bhala, who led the study.

He added: “These findings show significant differences in death rates by country of birth for both alcohol-related deaths and liver cancer. We now need to focus on developing new policy, research and practical action to help address these differences.”

The study has been published in the Journal of Public Health.(ANI)

Hepatitis Outbreak: 1 New Death Case In Gujarat’s Sabarkantha District; Death Toll Rises To 59

Hepatitis Outbreak: 1 New Death Case In Gujarat’s Sabarkantha District; Death Toll Rises To 59 In a shocking development, one more death case of hepatitis has come to light in Sabarkantha district of Gujarat.

But, health officials in the state are leaving no stone unturned to make sure that there no other person dies because of this viral disease.

Dr. H S Patel, chief district health officer (CDHO), told, “One death has been reported from the Idar taluka of the Sabarkantha. While two new cases of hepatitis have been reported from Idar and Vujaynagar talukas.”

With this the total number of people infected with hepatitis has risen to 235 in the state, of which 59 have died and 62 have been cured.

According to the reports, 8 hepatitis cases were reported from Idar, 3 from Modassa and 1 from Meghrak.

47 people have died due to the hepatitis infection in Modasa, whereas 9 deaths were reported in Meghraj taluka, two in Idar and one in Bayad.

Meanwhile, the health officials continued to attack on those who violate biomedical waste disposal norms, across the state.

Last week, the officials raided and sealed 13 godowns. Biomedical waste was stored in these godowns.

Apart from this, the state government earlier registered an FIR against 13 physicians including Dr. Govind Patel, for negligence of the hepatitis-B eruption. Around 3 were arrested for using unsterilised and used syringes, which was considered to be the cause of the outbreak.

The inquiries have disclosed that the majority of people who died in Modasa had undergone treatment from Patel.

The hepatitis-D virus (also called delta virus) is a small circular RNA virus and affects humans only in the presence of hepatitis-B infection. It is transmitted by blood and blood products. The risk factors for infection are similar to those for hepatitis-B virus infection.